Cortical Pathology in Vanishing White Matter
暂无分享,去创建一个
S. van der Sluis | D. Molenaar | M. Altelaar | M. S. van der Knaap | M. Bugiani | Marjolein Breur | Charlotte A. G. H. van Gelder | T. Abbink | Jodie H. K. Man | Daniel Okkes | J. H. Man | M. Breur
[1] K. Kuter,et al. Beyond the GFAP-Astrocyte Protein Markers in the Brain , 2021, Biomolecules.
[2] O. Elroy-Stein,et al. The Energy Status of Astrocytes Is the Achilles’ Heel of eIF2B-Leukodystrophy , 2021, Cells.
[3] Nadezhda T. Doncheva,et al. The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..
[4] Ya Chun Yu,et al. Glutamine reliance in cell metabolism , 2020, Experimental & Molecular Medicine.
[5] D. Downs,et al. RidA Proteins Protect against Metabolic Damage by Reactive Intermediates , 2020, Microbiology and Molecular Biology Reviews.
[6] Ulrike Winkler,et al. Heterogeneity of Astrocytes in Grey and White Matter , 2019, Neurochemical Research.
[7] Kyoko Watanabe,et al. Astrocyte Subtype Vulnerability in Stem Cell Models of Vanishing White Matter , 2019, Annals of neurology.
[8] S. van der Sluis,et al. Vanishing white matter: deregulated integrated stress response as therapy target , 2019, Annals of clinical and translational neurology.
[9] O. Elroy-Stein,et al. eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes , 2019, NeuroMolecular Medicine.
[10] Martin Eisenacher,et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data , 2018, Nucleic Acids Res..
[11] H. D. de Vet,et al. Natural History of Vanishing White Matter , 2018, Annals of neurology.
[12] M. S. van der Knaap,et al. Vanishing white matter: a leukodystrophy due to astrocytic dysfunction , 2018, Brain pathology.
[13] Maarten H. P. Kole,et al. Axonal abnormalities in vanishing white matter , 2018, Annals of clinical and translational neurology.
[14] O. Elroy-Stein. Mitochondrial malfunction in vanishing white matter disease: a disease of the cytosolic translation machinery , 2017, Neural regeneration research.
[15] M. S. van der Knaap,et al. Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms , 2017, Acta Neuropathologica.
[16] O. Elroy-Stein,et al. Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease , 2017, Journal of neurochemistry.
[17] Jüergen Cox,et al. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.
[18] Roland Eils,et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..
[19] M. Kamermans,et al. Astrocytes are central in the pathomechanisms of vanishing white matter. , 2016, The Journal of clinical investigation.
[20] E. Chang,et al. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse , 2016, Neuron.
[21] M. Norenberg,et al. Glutamine Synthetase: Role in Neurological Disorders. , 2016, Advances in neurobiology.
[22] C. Proud,et al. eIF2B: recent structural and functional insights into a key regulator of translation. , 2015, Biochemical Society transactions.
[23] E. Hol,et al. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. , 2015, Current opinion in cell biology.
[24] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[25] Arne V. Blackman,et al. Neuronal morphometry directly from bitmap images , 2014, Nature Methods.
[26] M. Nedergaard,et al. White matter astrocytes in health and disease , 2014, Neuroscience.
[27] C. Rose,et al. Astrocyte glutamine synthetase: pivotal in health and disease. , 2013, Biochemical Society transactions.
[28] Amin Derouiche,et al. Glutamine Synthetase as an Astrocytic Marker: Its Cell Type and Vesicle Localization , 2013, Front. Endocrinol..
[29] P. Scheffer,et al. Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease. , 2013, Brain : a journal of neurology.
[30] Christian Giaume,et al. Connexin-based intercellular communication and astrocyte heterogeneity , 2012, Brain Research.
[31] R. Wek,et al. Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism. , 2012, Advances in nutrition.
[32] E. Marcotte,et al. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses , 2012, Nature Reviews Genetics.
[33] H. Prange,et al. „Vanishing white matter disease“ , 2011, Der Nervenarzt.
[34] S. Goldman,et al. Defective Glial Maturation in Vanishing White Matter Disease , 2011, Journal of neuropathology and experimental neurology.
[35] G. Scheper,et al. Leukoencephalopathy With Vanishing White Matter: A Review , 2010, Journal of neuropathology and experimental neurology.
[36] E. Aronica,et al. GFAPδ in radial glia and subventricular zone progenitors in the developing human cortex , 2010, Development.
[37] E. Marcotte,et al. Global signatures of protein and mRNA expression levelsw , 2009 .
[38] T. Strom,et al. SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy , 2009, Nature Genetics.
[39] S. Scherer,et al. Gap Junctions Couple Astrocytes and Oligodendrocytes , 2008, Journal of Molecular Neuroscience.
[40] M. Freire,et al. Cajal's contributions to glia research , 2007, Trends in Neurosciences.
[41] B. Ransom,et al. Functional connexin “hemichannels”: A critical appraisal , 2006, Glia.
[42] K. Büssow,et al. Crystal structure of Homo sapiens protein hp14.5 , 2004, Proteins.
[43] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[44] R. Auer,et al. Embryonic intermediate filament, nestin, expression following traumatic spinal cord injury in adult rats , 2002, Neuroscience.
[45] A. Bizzi,et al. Cerebral White Matter Involvement in Children with Mitochondrial Encephalopathies , 2002, Neuropediatrics.
[46] S. Naidu,et al. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter , 2002, Annals of neurology.
[47] Rune R. Frants,et al. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter , 2001, Nature Genetics.
[48] W. Brück,et al. Myelinopathia centralis diffusa (vanishing white matter disease): Evidence of apoptotic oligodendrocyte degeneration in early lesion development , 2001, Annals of neurology.
[49] C. Proud,et al. Regulation of eukaryotic initiation factor eIF2B. , 2001, Progress in molecular and subcellular biology.
[50] A. Hart,et al. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. , 1999, Radiology.
[51] D. Rodriguez,et al. Phenotypic variation in leukoencephalopathy with vanishing white matter. , 1999, Neurology.
[52] C. Betsholtz,et al. Intermediate Filament Protein Partnership in Astrocytes* , 1999, The Journal of Biological Chemistry.
[53] D. Pham‐Dinh,et al. Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological and biochemical study of two cases , 1999, Acta Neuropathologica.
[54] F. Gabreëls,et al. A new leukoencephalopathy with vanishing white matter , 1997, Neurology.